160 related articles for article (PubMed ID: 30277140)
1. A Systematic Review on Anti-diabetic Properties of Chalcones.
Rocha S; Ribeiro D; Fernandes E; Freitas M
Curr Med Chem; 2020; 27(14):2257-2321. PubMed ID: 30277140
[TBL] [Abstract][Full Text] [Related]
2. Current anti-diabetic agents and their molecular targets: A review.
Kerru N; Singh-Pillay A; Awolade P; Singh P
Eur J Med Chem; 2018 May; 152():436-488. PubMed ID: 29751237
[TBL] [Abstract][Full Text] [Related]
3. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives.
Mahapatra DK; Asati V; Bharti SK
Eur J Med Chem; 2015 Mar; 92():839-65. PubMed ID: 25638569
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic drugs recent approaches and advancements.
Dowarah J; Singh VP
Bioorg Med Chem; 2020 Mar; 28(5):115263. PubMed ID: 32008883
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control.
Scheen AJ; Esser N; Paquot N
Diabetes Metab; 2015 Jun; 41(3):183-94. PubMed ID: 25794703
[TBL] [Abstract][Full Text] [Related]
6. Didymin, a dietary citrus flavonoid exhibits anti-diabetic complications and promotes glucose uptake through the activation of PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Ali MY; Zaib S; Rahman MM; Jannat S; Iqbal J; Park SK; Chang MS
Chem Biol Interact; 2019 May; 305():180-194. PubMed ID: 30928401
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-diabetic activity of flavonoids and pheophytins from Allophylus cominia Sw . on PTP1B, DPPIV, alpha-glucosidase and alpha-amylase enzymes.
Semaan DG; Igoli JO; Young L; Marrero E; Gray AI; Rowan EG
J Ethnopharmacol; 2017 May; 203():39-46. PubMed ID: 28341245
[TBL] [Abstract][Full Text] [Related]
8. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).
Abbas G; Al Harrasi A; Hussain H; Hamaed A; Supuran CT
Bioorg Chem; 2019 May; 86():305-315. PubMed ID: 30738330
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents.
Rammohan A; Bhaskar BV; Venkateswarlu N; Gu W; Zyryanov GV
Bioorg Chem; 2020 Jan; 95():103527. PubMed ID: 31911298
[TBL] [Abstract][Full Text] [Related]
10. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
[TBL] [Abstract][Full Text] [Related]
11. A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives.
Rocha S; Sousa A; Ribeiro D; Correia CM; Silva VLM; Santos CMM; Silva AMS; Araújo AN; Fernandes E; Freitas M
Food Funct; 2019 Sep; 10(9):5510-5520. PubMed ID: 31414099
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
13. Analogues of xanthones--Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates.
Cai CY; Rao L; Rao Y; Guo JX; Xiao ZZ; Cao JY; Huang ZS; Wang B
Eur J Med Chem; 2017 Apr; 130():51-59. PubMed ID: 28242551
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes.
Meng Q; Qi X; Fu Y; Chen Q; Cheng P; Yu X; Sun X; Wu J; Li W; Zhang Q; Li Y; Wang A; Bian H
J Ethnopharmacol; 2020 Feb; 248():112326. PubMed ID: 31639486
[TBL] [Abstract][Full Text] [Related]
15. The importance of synthetic drugs for type 2 diabetes drug discovery.
Safavi M; Foroumadi A; Abdollahi M
Expert Opin Drug Discov; 2013 Nov; 8(11):1339-63. PubMed ID: 24050217
[TBL] [Abstract][Full Text] [Related]
16. Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets.
He JH; Chen LX; Li H
Fitoterapia; 2019 Apr; 134():270-289. PubMed ID: 30840917
[TBL] [Abstract][Full Text] [Related]
17. Natural Prenylchalconaringenins and Prenylnaringenins as Antidiabetic Agents: α-Glucosidase and α-Amylase Inhibition and in Vivo Antihyperglycemic and Antihyperlipidemic Effects.
Sun H; Wang D; Song X; Zhang Y; Ding W; Peng X; Zhang X; Li Y; Ma Y; Wang R; Yu P
J Agric Food Chem; 2017 Mar; 65(8):1574-1581. PubMed ID: 28132506
[TBL] [Abstract][Full Text] [Related]
18. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.
Guthrie RM
Postgrad Med; 2015 Jun; 127(5):463-79. PubMed ID: 25956345
[TBL] [Abstract][Full Text] [Related]
20. Promising Inhibitory Effects of Anthraquinones, Naphthopyrone, and Naphthalene Glycosides, from Cassia obtusifolia on α-Glucosidase and Human Protein Tyrosine Phosphatases 1B.
Jung HA; Ali MY; Choi JS
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]